Maxcyte, Inc. · NASDAQ:MXCT
Cadian Capital Management, LP reported a 8.90% stake in Maxcyte, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Cadian Capital Management, LP reported a 8.90% stake in Maxcyte, Inc., 9,344,424 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 8.90%
- Shares
- 9,344,424
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cadian Capital Management, LP | 8.90% | 9,344,424 |
| Cadian Capital Management GP, LLC | 8.90% | 9,344,424 |
| ERIC BANNASCH | 8.90% | 9,344,424 |
Source
Related
- Maxcyte, Inc.
- Cadian Capital Management, LP
- Maxcyte, Inc. shareholders
- Schedule 13G/A · Cadian Capital Management, LP · Feb 17, 2026
- Schedule 13G/A · Cadian Capital Management, LP · Nov 14, 2025
- Schedule 13D · Liontrust Investment Partners LLP · Oct 15, 2026
- Schedule 13D · River Global Investors LLP · Aug 4, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Johnston John Joseph · Jun 22, 2026
- Form 4 · Hemrajani Rekha · Jun 22, 2026